BioCentury
ARTICLE | Clinical News

Oral interferon-alpha lozenges: Preliminary Phase II data

February 15, 2010 8:00 AM UTC

Preliminary data from a double-blind, placebo-controlled, Australian Phase II trial in 200 healthy volunteers vaccinated with the Fluvax influenza vaccine prior to the study showed that once-daily ora...